| PERIOD ENDING | 31-Oct-08 | 31-Oct-07 | 31-Oct-06 | | Total Revenue | 4,450 | 3,629 | 4,404 | | Cost of Revenue | 2,674 | 1,711 | 1,920 | | | Gross Profit | 1,776 | 1,919 | 2,484 | | | Operating Expenses | | Research Development |
-
|
-
|
-
| | Selling General and Administrative | 1,663 | 2,513 | 2,549 | | Non Recurring |
-
| 11 |
-
| | Others | 42 | 42 | 45 | | | | Total Operating Expenses |
-
|
-
|
-
| | | | Operating Income or Loss | 71 | (647) | (110) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 50 | (32) | 58 | | Earnings Before Interest And Taxes | 121 | (679) | (52) | | Interest Expense | 177 | 269 | 270 | | Income Before Tax | (56) | (948) | (322) | | Income Tax Expense |
-
|
-
|
-
| | Minority Interest |
-
|
-
|
-
| | | | Net Income From Continuing Ops | (56) | (948) | (322) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
| | Other Items |
-
|
-
|
-
| | | | Net Income | (56) | (948) | (322) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($56) | ($948) | ($322) |
|
1.48% Nasdaq 
Income Statement
